Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - April 2007

  1. Postmarketing Monitoring of Intussusception After RotaTeq Vaccination--United States, February 1, 2006-February 15, 2007.   MMWR Morb Mortal Wkly Rep; 56 (10): 218-222; March 16, 2007.

  2. Influenza Vaccination Coverage Among Children With Asthma--United States, 2004-05 Influenza Season.   MMWR Morb Mortal Wkly Rep; 56 (9): 193-196; March 9, 2007.

  3. Tackling Negative Perceptions Towards Vaccination.   Lancet Infect Dis; 7 (4): 235; April, 2007.

  4. Aballea, S.; Chancellor, J.; Martin, M.; Wutzler, P.; Carrat, F.; Gasparini, R.; Toniolo-Neto, J.; Drummond, M.; Weinstein, M.  The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: an International Model.   Value Health; 10 (2): 98-116; March, 2007.

  5. Abbas, M.; Fiala, L.; Tawfiq, L.  Workplace Influenza Vaccination in Two Major Industries in Saudi Arabia: a Cost Benefit Analysis.   J Egypt Public Health Assoc; 81 (1-2): 59-73; 2006.

  6. Ahrens, J.; Heuft, H. G.; Goudeva, L.; Przemeck, M.  Rhesus Immune Globulin Fails to Prevent Immunization After Rhesus Incompatible Blood Transfusion.   Transfus Apher Sci; March 14, 2007. [Epub ahead of print].

  7. Ancona, F.; Alfonsi, V.; Caporali, M.; Ranghiasci, A.; Ciofi Degli, Atti M.  Pneumococcal Conjugate, Meningococcal C and Varicella Vaccination in Italy.   Euro Surveill; 12 (2); February, 2007.

  8. Appel, S.; Chapman, J.; Shoenfeld, Y.  Infection and Vaccination in Chronic Fatigue Syndrome: Myth or Reality?   Autoimmunity; 40 (1): 48-53; February, 2007.

  9. Arenas-Garcia, L.; Garcia-Corp; Martinez-Gurrion, L. A.; Martinez-Mendoza, L. A.; Cortina-Jacobo, S.; Noyola, D. E.  Acceptance of Influenza Vaccination by Nursing Personnel in Mexico.   J Hosp Infect; March 9, 2007. [Epub ahead of print].

  10. Bakare, M.; Shrivastava, R.; Jeevanantham, V.; Navaneethan, S. D.  Impact of Two Different Models on Influenza and Pneumococcal Vaccination in Hospitalized Patients.   South Med J; 100 (2): 140-144; February, 2007.

  11. Bowerman, R. J.  Community-Wide INH Treatment of Latent TB Infection in a BCG-Vaccinated Population: Experience in Rural Taiwan.   Int J Tuberc Lung Dis; 11 (4): 470-472; April, 2007.

  12. Bren, L.  Influenza: Vaccination Still the Best Protection.   FDA Consum; 40 (5): 12-19; September, 2006.

  13. Brewer, N. T.; Chapman, G. B.; Gibbons, F. X.; Gerrard, M.; McCaul, K. D.; Weinstein, N. D.  Meta-Analysis of the Relationship Between Risk Perception and Health Behavior: the Example of Vaccination.   Health Psychol; 26 (2): 136-145; March, 2007.

  14. Brown, N. J.; Berkovic, S. F.; Scheffer, I. E.  Vaccination, Seizures and 'Vaccine Damage'.   Curr Opin Neurol; 20 (2): 181-187; April, 2007.

  15. Burwen, D. R.; La, Voie L.; Braun, M. M.; Houck, P.; Ball, R.  Evaluating Adverse Events After Vaccination in the Medicare Population.   Pharmacoepidemiol Drug Saf; March 27, 2007. [Epub ahead of print].

  16. Carter-Arrowsmith, P.  Vaccinating Infants With a Wide Long Needle Achieved Comparable Immune Response and Reduced Local Reactions Compared With a Narrow Short Needle.   Evid Based Nurs; 10 (2): 43; April, 2007.

  17. Centkowski, P.; Brydak, L.; Machala, M.; Kalinka-Warzocha, E.; Blasinska-Morawiec, M.; Federowicz, I.; Walewski, J.; Wc E Grzyn; Wolowiec, D.; Lech-Maranda, E.; Sawczuk-Chabin, J.; Bilinski, P.; Warzocha, K.  Immunogenicity of Influenza Vaccination in Patients With Non-Hodgkin Lymphoma.   J Clin Immunol; March 8, 2007. [Epub ahead of print].

  18. Crosby, R.; Schoenberg, N.; Hopenhayn, C.; Moore, G.; Melhan, W.  Correlates of Intent to Be Vaccinated Against Human Papillomavirus: an Exploratory Study of College-Aged Women.   Sex Health; 4 (1): 71-73; March, 2007.

  19. d'Onofrio, A.; Manfredi, P.; Salinelli, E.   Vaccinating Behaviour, Information, and the Dynamics of SIR Vaccine Preventable Diseases.   Theor Popul Biol; 71 (3): 301-317; January 14, 2007.

  20. Datar, A.; Mukherji, A.; Sood, N.  Health Infrastructure & Immunization Coverage in Rural India.   Indian J Med Res; 125 (1): 31-42; January, 2007.

  21. Davis, D. B.; Lalonde, A. B.  Interim Statement on HPV Immunization.   J Obstet Gynaecol Can; 29 (1): 61, 62; January, 2007.

  22. De Ory, F.; Sanz, J. C.; Garcia, Bermejo, I   [Triple Vaccination: Old Viruses, New Problems.].   Enferm Infecc Microbiol Clin; 25 (4): 227-229; April, 2007.

  23. Del Villar-Belzunce, A.; Hernandez-Navarrete, M. J.; Lapresta-Moros, C.; Solano-Bernad, V. M.; rribas-Llorente, J. L.  [Flu Vaccination in Healthcare Workers.].   Enferm Infecc Microbiol Clin; 25 (4): 247-249; April, 2007.

  24. Dempsey, A. F.  Vaccination Against Human Papillomavirus.   Am J Manag Care; 12 (17 Suppl): S460-S461; December, 2006.

  25. Donalisio, M. R.  Brazilian Policy for Influenza Vaccination and Its Impact on the Health of the Elderly.   Cad Saude Publica; 23 (3): 494-495; March, 2007.

  26. Faruqi, N.; Ramsey, K. M.  The Challenge of Vaccinating Hospitalized Patients for Influenza and Pneumococcus.   South Med J; 100 (2): 125-126; February, 2007.

  27. Franzini, L.; Boom, J.; Nelson, C.  Cost-Effectiveness Analysis of a Practice-Based Immunization Education Intervention.   Ambul Pediatr; 7 (2): 167-175; March, 2007.

  28. Frati, F.; Moingeon, P.; Marcucci, F.; Puccinelli, P.; Sensi, L.; Di, Cara G.; Incorvaia, C.  Mucosal Immunization Application to Allergic Disease: Sublingual Immunotherapy.   Allergy Asthma Proc; 28 (1): 35-39; January, 2007.

  29. Frayha, H.; Alrajhi, A. A.  Reply: Influenza Vaccination.   Ann Saudi Med; 19 (1): 62-63; January, 1999.

  30. Frayha, H. H.; Alrajhi, A. A.  Influenza Vaccination: A Call for Action.   Ann Saudi Med; 17 (6): 587-589; November, 1997.

  31. Fuller, C. L.; Brittingham, K. C.; Porter, M. W.; Hepburn, M. J.; Petitt, P. L.; Pittman, P. R.; Bavari, S.  Transcriptome Analysis of Human Immune Responses Following Live Vaccine Strain (LVS) Francisella Tularensis Vaccination.   Mol Immunol; 44(12): 3173-3184; March 7, 2007.

  32. Galvani, A. P.; Reluga, T. C.; Chapman, G. B.  Long-Standing Influenza Vaccination Policy Is in Accord With Individual Self-Interest but Not With the Utilitarian Optimum.   Proc Natl Acad Sci U S A; 104 (13): 5692-5697; March 27, 2007.

  33. Gautret, P.; Parola, P.; Shaw, M.; Torresi, J.  Rabies Preexposure Vaccination in Travelers.   J Travel Med; 14 (2): 136; March, 2007.

  34. Gjersvik, P.  [Children Die Without Vaccination Against Measles].   Tidsskr Nor Laegeforen; 127 (6): 770; March 15, 2007.

  35. Hamkar, R.; Mahmoodi, M.; Nategh, R.; Jelyani, K. N.; Eslami, M. B.; Mohktari-Azad, T.  Distinguishing Between Primary Measles Infection and Vaccine Failure Reinfection by IgG Avidity Assay.   East Mediterr Health J; 12 (6): 775-782; November, 2006.

  36. Hammer, A. L.; Leger, V. J.  Improving Pediatric Immunization Rates in a Safety-Net Delivery System Denver Health Wins 2006 JCAHO Codman Quality Award.   Colo Nurse; 107 (1): 18; March, 2007.

  37. Harris, J. P.; Jit, M.; Cooper, D.; Edmunds, W. J.  Evaluating Rotavirus Vaccination in England and Wales Part I. Estimating the Burden of Disease.   Vaccine; March 15, 2007. [Epub ahead of print].

  38. Hawgood, B. J.  Waldemar Mordecai Haffkine, CIE (1860-1930): Prophylactic Vaccination Against Cholera and Bubonic Plague in British India.   J Med Biogr; 15 (1): 9-19; February, 2007.

  39. Hobson-West, P.  'Trusting Blindly Can Be the Biggest Risk of All': Organised Resistance to Childhood Vaccination in the UK.   Sociol Health Illn; 29 (2): 198-215; March, 2007.

  40. Hubben, G. A.; Bos, J. M.; Glynn, D. M.; van der, Ende A.; van, Alphen L.; Postma, M. J.  Enhanced Decision Support for Policy Makers Using a Web Interface to Health-Economic Models-Illustrated With a Cost-Effectiveness Analysis of Nation-Wide Infant Vaccination With the 7-Valent Pneumococcal Conjugate Vaccine in the Netherlands.   Vaccine; 25(18): 3669-3679; February 5, 2007.

  41. Inostroza, J.; Illesca, V.; Reydet, P.; Vinet, A. M.; Ossa, G.; Munoz, S.; Thompson, T.; Sorensen, R. U.  Ten-Year Surveillance of Pneumococcal Infections in Temuco, Chile. Implications for Vaccination Strategies.   Clin Vaccine Immunol; March 28, 2007. [Epub ahead of print].

  42. Jackson, L. A.; Neuzil, K. M.; Nahm, M. H.; Whitney, C. G.; Yu, O.; Nelson, J. C.; Starkovich, P. T.; Dunstan, M.; Carste, B.; Shay, D. K.; Baggs, J.; Carlone, G. M.  Immunogenicity of Varying Dosages of 7-Valent Pneumococcal Polysaccharide-Protein Conjugate Vaccine in Seniors Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine.   Vaccine; March 12, 2007. [Epub ahead of print].

  43. Jacob, John T.  Quo Vadis, Expanded Programme on Immunization?   Indian J Med Res; 125 (1): 13-16; January, 2007.

  44. Jegede, A. S.  What Led to the Nigerian Boycott of the Polio Vaccination Campaign?   PLoS Med; 4 (3): e73; March, 2007.

  45. Kafetzis, D. A.; Stamboulidis, K. N.; Tzanakaki, G.; Kourea, Kremastinou J.; Skevaki, C. L.; Konstantopoulos, A.; Tsolia, M.  Meningococcal Group C Disease in Greece During 1993-2006: the Impact of an Unofficial Single-Dose Vaccination Scheme Adopted by Most Paediatricians.   Clin Microbiol Infect; 13(5): 550-552; March 22, 2007.

  46. Kahn, J.  What Vaccination Programs Mean for Research.   Am J Bioeth; 7 (3): 3-4; March, 2007.

  47. Lawrence, G.; Boyd, I.  Supplementary Report: Surveillance of Adverse Events Following Immunisation Among Children Aged < 7 Years in Australia, 1 January to 30 June 2006.   Commun Dis Intell; 30 (4): 438-442; 2006.

  48. Lee, T. A.; Weaver, F. M.; Weiss, K. B.  Impact of Pneumococcal Vaccination on Pneumonia Rates in Patients With COPD and Asthma.   J Gen Intern Med; 22 (1): 62-67; January, 2007.

  49. Lester, S. K.; Hayney, M. S.  Expanding Childhood Influenza Immunization Recommendations.   J Am Pharm Assoc (Wash DC ); 47 (1): 104-105; January, 2007.

  50. Lin, Y. C.; Yao, S. M.; Yan, J. J.; Chen, Y. Y.; Chiang, C. S.; Wu, H. S.; Li, S. Y.  Epidemiological Shift in the Prevalence of Pertussis in Taiwan: Implications for Pertussis Vaccination.   J Med Microbiol; 56 (Pt 4): 533-537; April, 2007.

  51. Lindberg, A.; Tegnell, A.  [Who Is to Inform and Who Is to Vaccinate? About New Vaccines and Vaccinations Outside the General Programs].   Lakartidningen; 104 (7): 490-492; February 14, 2007.

  52. Linehan, M. F.; Frank, T. L.; Hazell, M. L.; Francis, H. C.; Morris, J. A.; Baxter, D. N.; Niven, R. M.  Is the Prevalence of Wheeze in Children Altered by Neonatal BCG Vaccination?   J Allergy Clin Immunol; March, 2007. [Epub ahead of print].

  53. Lopalco, P. L.; Giesecke, J.  Panel of International Experts Concludes on Influenza and Pneumococcal Vaccination in Europe.   Euro Surveill; 12 (1): E070118; January 18, 2007.

  54. Lorgelly, P. K.; Joshi, D.; Iturriza, Gomara M.; Gray, J.; Mugford, M.  Exploring the Cost Effectiveness of an Immunization Programme for Rotavirus Gastroenteritis in the United Kingdom.   Epidemiol Infect;1-12; March 5, 2007.

  55. McCann, L. J.  Should Children Under Treatment for Juvenile Idiopathic Arthritis Receive Flu Vaccination?   Arch Dis Child; 92 (4): 366-368; April, 2007.

  56. McLennan, S.; Celi, L. A.; Roth, P.  The Health and Safety in Employment Act and the Influenza Vaccination of Healthcare Workers.   N Z Med J; 120 (1250): U2442; March 2, 2007.

  57. Meadows, M.  Keeping Up With Vaccines.   FDA Consum; 41 (1): 23-31; January, 2007.

  58. Minden, K.; Niewerth, M.; Borte, M.; Singendonk, W.; Haas, J. P.  [Immunization in Children and Adolescents With Rheumatic Diseases.].   Z Rheumatol; 66 (2): 111-120; March, 2007.

  59. Mittal, S. K.; Mathew, J. L.  Polio Eradication in India: the Way Forward.   Indian J Pediatr; 74 (2): 153-160; February, 2007.

  60. Newall, A. T.; Beutels, P.; Wood, J. G.; Edmunds, W. J.; Macintyre, C. R.  Cost-Effectiveness Analyses of Human Papillomavirus Vaccination.   Lancet Infect Dis; 7 (4): 289-296; April, 2007.

  61. Nikkels, A. F.; Pierard, G. E.  [How I Prevent...Herpes Zoster by Vaccination].   Rev Med Liege; 62 (1): 44-47; January, 2007.

  62. Pastore, Celentano L.; Lopalco, P. L.; O'Flanagan, D.; Levy-Bruhl, D.; Ferro, A.; Tridente, G.; Appelgren, E.; Salmaso, S.  VENICE: Europe's New Network for Vaccination.   Euro Surveill; 12 (1): E070118; January 18, 2007.

  63. Pearson, E.; Lang, E.; Colacone, A.; Farooki, N.; Afilalo, M.  Successful Implementation of a Combined Pneumococcal and Influenza Vaccination Program in a Canadian Emergency Department.   CJEM; 7 (6): 371-377; November, 2005.

  64. Perot, A.; Kazaz, E. S.; Morgny, C.; Portier, H.  [Vaccination Status of Burgundy Inhabitants: a Survey in Various Institutions.].   Med Mal Infect; February 28, 2007. [Epub ahead of print].

  65. Ridda, I.; Macintyre, R. C.; Lindley, R. I.; McIntyre, P. B.; Sullivan, J.; Gilbert, G.; Kovoor, P.; Manolios, N.; Fox, J.   Predictors of Pneumococcal Vaccination Uptake in Hospitalized Patients Aged 65 Years and Over Shortly Following the Commencement of a Publicly Funded National Pneumococcal Vaccination Program in Australia.   Hum Vaccin; 3 (3): 57-60; May 30, 2007.

  66. Rifkin, W. D.; Berger, A.; Holmboe, E. S.; Sturdevant, B.  Comparison of Hospitalists and Nonhospitalists Regarding Core Measures of Pneumonia Care.   Am J Manag Care; 13 (3): 129-132; March, 2007.

  67. Root-Bernstein, R.  Positive Vaccination Markers.   Hum Vaccin; 3 (3): 78-79; May 11, 2007.

  68. Rouzier, R.  [Prevention: New Whooping Cough Vaccination Guidelines.].   J Gynecol Obstet Biol Reprod (Paris); March 14, 2007. [Epub ahead of print].

  69. Sakata, H.  Invasive Haemophilus Influenzae Infections in Children in Kamikawa Subprefecture, Hokkaido, Japan, 1996-2005, Before the Introduction of H. Influenzae Type b Vaccination.   J Infect Chemother; 13 (1): 30-34; February, 2007.

  70. Saluja, I.; Theakston, K. D.; Kaczorowski, J.  Influenza Vaccination Rate Among Emergency Department Personnel: a Survey of Four Teaching Hospitals.   CJEM; 7 (1): 17-21; January, 2005.

  71. Sengupta, N.; Booy, R.; Schmitt, H. J.; Peltola, H.; Van-Damme, P.; Schumacher, R. F.; Campins, M.; Rodrigo, C.; Heikkinen, T.; Seward, J.; Jumaan, A.; Finn, A.; Olcen, P.; Thiry, N.; Weil-Olivier, C.; Breuer, J.  Varicella Vaccination in Europe: Are We Ready for a Universal Childhood Programme?   Eur J Pediatr; March 3, 2007. [Epub ahead of print].

  72. Singh, R.; Gupta, S. K.  BCG Immunization: Is It Really Efficacious and Cost-Effective?   Natl Med J India; 19 (6): 323-324; November, 2006.

  73. Skeet, J.  Rabies Vaccination and Post-Exposure Prophylaxis.   Nurs Times; 103 (10): 45, 47; March 6, 2007.

  74. Smith, B.; Leard, C. A.; Smith, T. C.; Reed, R. J.; Ryan, M. A.  Anthrax Vaccination in the Millennium Cohort Validation and Measures of Health.   Am J Prev Med; 32 (4): 347-353; April, 2007.

  75. Spooner, S. A.  Special Requirements of Electronic Health Record Systems in Pediatrics.   Pediatrics; 119 (3): 631-637; March, 2007.

  76. Tarrago, D.; Aguilar, L.; Jansen, W. T.; Gimenez, M. J.; Avellon, A.; Granizo, J. J.; Casal, J.  Dependence of Correlations Between Antibody Titres and Opsonophagocytosis on Pneumococcal Serotype and Patient Morbidity in Pre- and Post-Pneumococcal Vaccination States.   Clin Microbiol Infect; 13 (4): 369-376; March, 2007.

  77. Thacker, N.  Polio Eradication: Window of Opportunity!   Indian Pediatr; 44 (2): 81-82; February, 2007.

  78. Tsai, Y. W.; Huang, W. F.; Wen, Y. W.; Chen, P. F.  The Relationship Between Influenza Vaccination and Outpatient Visits for Upper Respiratory Infection by the Elderly in Taiwan.   Value Health; 10 (2): 117-127; March, 2007.

  79. Uma, A.; Thirumalaikolundusubramanian, P.  Influenza Vaccination.   Ann Saudi Med; 19 (1): 62; January, 1999.

  80. Vajdy, M.; Baudner, B.; Del, Giudice G.; O'hagan, D.  A Vaccination Strategy to Enhance Mucosal and Systemic Antibody and T Cell Responses Against Influenza.   Clin Immunol; March 7, 2007. [Epub ahead of print].

  81. Vauloup-Fellous, C.; Grangeot-Keros, L.  HUMORAL IMMUNE RESPONSE AFTER RUBELLA PRIMARY INFECTION AND AFTER VACCINATION.   Clin Vaccine Immunol; March 7, 2007. [Epub ahead of print].

  82. Verani, J. R.; Irigoyen, M.; Chen, S.; Chimkin, F.  Influenza Vaccine Coverage and Missed Opportunities Among Inner-City Children Aged 6 to 23 Months: 2000-2005.   Pediatrics; 119 (3): e580-e586; March, 2007.

  83. Ward, L.; Draper, J.  A Review of the Factors Involved in Older People's Decision Making With Regard to Influenza Vaccination: a Literature Review.   J Clin Nurs; March 30, 2007. [Epub ahead of print].

  84. Weaver, F. M.; Smith, B.; LaVela, S.; Wallace, C.; Evans, C. T.; Hammond, M.; Goldstein, B.  Interventions to Increase Influenza Vaccination Rates in Veterans With Spinal Cord Injuries and Disorders.   J Spinal Cord Med; 30 (1): 10-19; 2007.

  85. Weinstein, N. D.; Kwitel, A.; McCaul, K. D.; Magnan, R. E.; Gerrard, M.; Gibbons, F. X.  Risk Perceptions: Assessment and Relationship to Influenza Vaccination.   Health Psychol; 26 (2): 146-151; March, 2007.

  86. Yip, P. S.; Watson, R.; Chen, Q.  Estimation of Vaccine Efficacy and the Vaccination Threshold.   Stat Med; March 9, 2007. [Epub ahead of print].

  87. Zagminas, K.; Surkiene, G.; Urbanovic, N.; Stukas, R.  [Parental Attitudes Towards Children's Vaccination].   Medicina (Kaunas ); 43 (2): 161-169; 2007.